Indianapolis Business Journal

JANUARY 14-20, 2011

This week, see what new tactic the national American Legion is using to shore up its bottom line and find out what effect repeated price cuts had on Endocyte's initial IPO. In Focus, find out how city boosters are looking to supplement local convention business. And in Forefront, columnists weigh in on topics such as  social discourse, taxes, grading teachers, political conventions and the North of South development.

Front PageBack to Top

Top StoriesBack to Top

FocusBack to Top

OpinionBack to Top

WellPoint exec’s complaint is ironic

A survey last year by the Center for American Progress Action Fund found that double-digit hikes were implemented or were pending in at least 11 other states among the 14 where WellPoint’s Blue Cross Blue Shield companies are active.

Read More

Brokers work as difference-makers

Our industry is poised to change, but you missed what’s happening not only in our firm every day, but with our peers in the field that have long since fought against the natural trends of our industry in order to provide value and create solid outcomes—to be difference-makers.

Read More

In BriefBack to Top

Recent successes don’t change Lilly’s outlook

Eli Lilly and Co. can be credited with using acquisitions to unclog its product pipeline. It launched two drugs in the past 18 months, won market approval for a third and will likely get nods for two more drugs this year. Trouble is, they all have paltry sales prospects.

Read More